MedImmune reports positive data in lupus medication test
Positive data has been received from the Phase II trial for anifrolumab, according to an announcement from MedImmune, which is the development and research portion of AstraZeneca. Read More »
Positive data has been received from the Phase II trial for anifrolumab, according to an announcement from MedImmune, which is the development and research portion of AstraZeneca. Read More »
Genentech's drug Cotellic was approved by the U.S. Food and Drug Administration (FDA) this week as a combination treatment for advanced melanoma. Read More »
Allergan has applied for a prior approval supplement (PAS) for Restatsis -- a medication to help patients who suffer from chronic eye dryness increase the production of tears -- according to a Nov. 11 announcement. Read More »
Elsevier will be the publisher of all American Pharmacists Association (APhA) publications starting Jan. 1. Read More »
ZS Pharma is set to be acquired by AstraZeneca, according to announcement today from AstraSeneca. Read More »
The National Association of Chain Drug Stores (NACDS) Foundation recently promoted Sara Roszak to research programs director. Read More »
An analysis of clinical trials of Praluent showed that trial participants had a lower LDL cholesterol after the eight-week trial, according an announcement from Sanofi and Regeneron Pharmaceuticals Inc. Read More »
The Pharmacy Practice Model Initiative has been renamed Practice Advancement Initiative (PAI), according to an announcement from the American Society of Health-System Pharmacists (ASHP) Foundation and the ASHP. Read More »
Out of concern for the individuals that use its branded medicines, Horizon Pharma announced Wednesday that it is re-evaluating its relationship with pharmacy benefit manager Express Scripts. Read More »
Hospice Pharmacy Solutions of Dallas, a pharmacy benefit management (PBM) service, announced Monday that it has merged with Sacramento-based hospice PBM Outcome Resources. Read More »
Clinical-stage biopharmaceutical company Novavax said Monday it has started a Phase 3 clinical trial of its vaccine for the protection against respiratory syncytial virus (RSV) in older adults. Read More »
Walgreens recently said it will begin implementing Epic System's electric health record (EHR) platform across its more than 400 in-store health care clinics around the nation early next year. Read More »
Findings from a recent survey by Cigna analyzing workplace wellness in India were released last week during a forum sponsored by Cigna TTK Health Insurance Company Limited, joint venture between Cigna and Indian conglomerate TTK Group. Read More »
Allergan has entered into a $50 million licensing deal to develop and commercialize tavilermide (MIM-D3), Mimetogen Pharmaceutical's lead product for the treatment of dry eye syndrome (DES). Read More »
AstraZeneca has entered into a deal to acquire ZS Pharma for $2.7 billion, giving AstraZeneca access to ZS Pharma's treatments for hyperkalemia. Read More »
Clinical studies showed that Nucala was effective in reducing exacerbations that would require hospitalization. Read More »
The American Society of Hematology's annual meeting taking place Dec. 5 to Dec. 8 in Orlando, Florida. Read More »
PharMerica Corp. announced Thursday that it has completed its acquisition of Luker Pharmacy Management, although terms were not publicly disclosed. Read More »
Johnson & Johnson said this week it has entered a deal to acquire hepatitis B virus (HBV) drug developer Novira Therapeutics Inc. by the end of the year. Read More »
Maine residents will now have easy access to high-quality medical care with the opening of the first MinuteClinics in the state this week. Read More »